Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6009698 | eNeurologicalSci | 2017 | 22 Pages |
Abstract
In patients with ALS, glucose metabolism decreased in the impaired side of the primary motor cortex depending on the clinical symptom progression in the corresponding extremities, regardless of the presence of clinical UMN signs. A decrement in glucose metabolism on FDG-PET corresponding to symptoms in the primary motor cortex might be an indicator of the time-dependent course of ALS neurodegeneration.
Keywords
Related Topics
Life Sciences
Neuroscience
Endocrine and Autonomic Systems
Authors
Hironobu Endo, Kenji Sekiguchi, Takehiro Ueda, Hisatomo Kowa, Fumio Kanda, Tatsushi Toda,